The final, formatted version of the article will be published soon.
EDITORIAL article
Front. Bioinform.
Sec. Integrative Bioinformatics
Volume 4 - 2024 |
doi: 10.3389/fbinf.2024.1470107
This article is part of the Research Topic Big data and artificial intelligence for genomics and therapeutics – Proceedings of the 19th Annual Meeting of the MidSouth Computational Biology and Bioinformatics Society (MCBIOS) View all 7 articles
Editorial: Big Data and Artificial Intelligence for Genomics and Therapeutics -Proceedings of the 19th Annual Meeting of the MidSouth Computational Biology and Bioinformatics Society (MCBIOS)
Provisionally accepted- 1 United States Food and Drug Administration, Silver Spring, United States
- 2 University of Dallas, Irving, Texas, United States
- 3 University of Mississippi, Oxford, Mississippi, United States
- 4 Emory University, Atlanta, Georgia, United States
Keywords: big data, bioinformatics, Artifici al Intelligence, Genomics, Therapeutics
Received: 25 Jul 2024; Accepted: 29 Jul 2024.
Copyright: © 2024 Hong, Toby-Ogundeji, Doerksen and Qin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Huixiao Hong, United States Food and Drug Administration, Silver Spring, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.